FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124628149> ?p ?o ?g. }

• W2124628149 abstract "Recent studies showed that the non-adherence to the pharmacological therapy of patients affected by BPH-associated LUTS increased the risk of clinical progression of BPH. We examined the patients adherence to pharmacological therapy and its clinical consequences in men with BPH-associated LUTS looking at the differences between drug classes comparing mono vs combination therapy.A retrospective, population-based cohort study, using prescription administrative database and hospital discharge codes from a total of 1.5 million Italian men. Patients ≥ 40 years, administered alpha-blockers (AB) and 5alpha-reductase inhibitors (5ARIs), alone or in combination (CT), for BPH-associated LUTS were analyzed. The 1-year and long term adherence together with the analyses of hospitalization rates for BPH and BPH-related surgery were examined using multivariable Cox proportional hazards regression model and Pearson chi square test.Patients exposed to at least 6 months of therapy had a 1-year overall adherence of 29 % (monotherapy AB 35 %, monotherapy 5ARI 18 %, CT 9 %). Patient adherence progressively declined to 15 %, 8 % and 3 % for AB, 5ARI, and CT, respectively at the fifth year of follow up. Patients on CT had a higher discontinuation rate along all the follow-up compared to those under monotherapy with ABs or 5ARIs (all p < 0.0001). Moreover, CT was associated with a reduced risk of hospitalization for BPH-related surgery (HR 0.94; p < 0.0001) compared to AB monotherapy.Adherence to pharmacological therapy of BPH-associated LUTS is low and varies depending on drugs class. Patients under CT have a higher likelihood of discontinuing treatment for a number of reasons that should be better investigated. Our study suggests that new strategies aiming to increase patient's adherence to the prescribed treatment are necessary in order to prevent BPH progression." @default.
• W2124628149 created "2016-06-24" @default.
• W2124628149 creator A5033387762 @default.
• W2124628149 creator A5043479332 @default.
• W2124628149 creator A5046595616 @default.
• W2124628149 creator A5060396382 @default.
• W2124628149 creator A5061191487 @default.
• W2124628149 creator A5070567916 @default.
• W2124628149 creator A5074536139 @default.
• W2124628149 creator A5080988702 @default.
• W2124628149 creator A5083952077 @default.
• W2124628149 creator A5085221826 @default.
• W2124628149 creator A5086694069 @default.
• W2124628149 date "2015-09-21" @default.
• W2124628149 modified "2023-10-12" @default.
• W2124628149 title "Patient’s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?" @default.
• W2124628149 cites W1575778540 @default.
• W2124628149 cites W1925520630 @default.
• W2124628149 cites W1970782054 @default.
• W2124628149 cites W1980122321 @default.
• W2124628149 cites W1995256786 @default.
• W2124628149 cites W1996112222 @default.
• W2124628149 cites W1998592319 @default.
• W2124628149 cites W2005179743 @default.
• W2124628149 cites W2005687876 @default.
• W2124628149 cites W2009604837 @default.
• W2124628149 cites W2010788532 @default.
• W2124628149 cites W2014035386 @default.
• W2124628149 cites W2018377518 @default.
• W2124628149 cites W2026458617 @default.
• W2124628149 cites W2031383171 @default.
• W2124628149 cites W2038693293 @default.
• W2124628149 cites W2053780376 @default.
• W2124628149 cites W2055815721 @default.
• W2124628149 cites W2060205275 @default.
• W2124628149 cites W2062573956 @default.
• W2124628149 cites W2070153213 @default.
• W2124628149 cites W2081597080 @default.
• W2124628149 cites W2106355635 @default.
• W2124628149 cites W2109238714 @default.
• W2124628149 cites W2121759271 @default.
• W2124628149 cites W2142727765 @default.
• W2124628149 cites W2144563350 @default.
• W2124628149 cites W2321031816 @default.
• W2124628149 cites W2783639780 @default.
• W2124628149 doi "https://doi.org/10.1186/s12894-015-0090-x" @default.
• W2124628149 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4578263" @default.
• W2124628149 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26391357" @default.
• W2124628149 hasPublicationYear "2015" @default.
• W2124628149 type Work @default.
• W2124628149 sameAs 2124628149 @default.
• W2124628149 citedByCount "58" @default.
• W2124628149 countsByYear W21246281492015 @default.
• W2124628149 countsByYear W21246281492016 @default.
• W2124628149 countsByYear W21246281492017 @default.
• W2124628149 countsByYear W21246281492018 @default.
• W2124628149 countsByYear W21246281492019 @default.
• W2124628149 countsByYear W21246281492020 @default.
• W2124628149 countsByYear W21246281492021 @default.
• W2124628149 countsByYear W21246281492022 @default.
• W2124628149 countsByYear W21246281492023 @default.
• W2124628149 crossrefType "journal-article" @default.
• W2124628149 hasAuthorship W2124628149A5033387762 @default.
• W2124628149 hasAuthorship W2124628149A5043479332 @default.
• W2124628149 hasAuthorship W2124628149A5046595616 @default.
• W2124628149 hasAuthorship W2124628149A5060396382 @default.
• W2124628149 hasAuthorship W2124628149A5061191487 @default.
• W2124628149 hasAuthorship W2124628149A5070567916 @default.
• W2124628149 hasAuthorship W2124628149A5074536139 @default.
• W2124628149 hasAuthorship W2124628149A5080988702 @default.
• W2124628149 hasAuthorship W2124628149A5083952077 @default.
• W2124628149 hasAuthorship W2124628149A5085221826 @default.
• W2124628149 hasAuthorship W2124628149A5086694069 @default.
• W2124628149 hasBestOaLocation W21246281491 @default.
• W2124628149 hasConcept C121608353 @default.
• W2124628149 hasConcept C126322002 @default.
• W2124628149 hasConcept C126894567 @default.
• W2124628149 hasConcept C167135981 @default.
• W2124628149 hasConcept C207103383 @default.
• W2124628149 hasConcept C2775874879 @default.
• W2124628149 hasConcept C2776235491 @default.
• W2124628149 hasConcept C2776999253 @default.
• W2124628149 hasConcept C2778715236 @default.
• W2124628149 hasConcept C2779478474 @default.
• W2124628149 hasConcept C2780435053 @default.
• W2124628149 hasConcept C2910366748 @default.
• W2124628149 hasConcept C44249647 @default.
• W2124628149 hasConcept C50382708 @default.
• W2124628149 hasConcept C71924100 @default.
• W2124628149 hasConceptScore W2124628149C121608353 @default.
• W2124628149 hasConceptScore W2124628149C126322002 @default.
• W2124628149 hasConceptScore W2124628149C126894567 @default.
• W2124628149 hasConceptScore W2124628149C167135981 @default.
• W2124628149 hasConceptScore W2124628149C207103383 @default.
• W2124628149 hasConceptScore W2124628149C2775874879 @default.
• W2124628149 hasConceptScore W2124628149C2776235491 @default.
• W2124628149 hasConceptScore W2124628149C2776999253 @default.
• W2124628149 hasConceptScore W2124628149C2778715236 @default.
• W2124628149 hasConceptScore W2124628149C2779478474 @default.
• W2124628149 hasConceptScore W2124628149C2780435053 @default.

• next